Bank of New York Mellon’s InspireMD NSPR Stock Holding History

Bank of New York Mellon’s Portfolio NSPR Stock Details NSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,596	Closed	-$82K	–	4240
2019 Q2	$82K	Buy	+1,596	New	+$98.9K	﹤0.01%	4057
2018 Q1	–	Sell	-4	Closed	-$13K	–	4386
2017 Q4	$13K	Buy	4 +3	+300%	+$24.8K	﹤0.01%	4322
2017 Q3	$9K	Buy	+1	New	+$10.7K	﹤0.01%	4245
2017 Q1	–	Hold	0	–	-$31K	–	4307
2016 Q4	–	Hold	0	–	–	–	4176

Other funds holding NSPR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of New York Mellon's NSPR Position: Q3 2019 in Review

Bank of New York Mellon sold out of InspireMD (NSPR) in Q3 2019, closing a stake of 1,596 shares — an estimated $82K sold.

Bank of New York Mellon first reported a position in NSPR in Q3 2017 and held it in 3 quarters. The position peaked at $82K in Q2 2019. 7 funds tracked by Wall St. Rank hold NSPR as of Q3 2019.

Bank of New York Mellon reported no remaining InspireMD position as of Q3 2019 after selling out during the quarter.
Bank of New York Mellon sold 1,596 InspireMD shares in Q3 2019, an estimated $82K.
Bank of New York Mellon first reported a position in InspireMD in Q3 2017 and held it in 3 quarters.
Bank of New York Mellon's InspireMD position peaked at $82K in Q2 2019.
7 funds tracked by Wall St. Rank held InspireMD as of Q3 2019.

Based on Bank of New York Mellon's 13F filing for Q3 2019, filed 7 Nov 2019.